Skip to main content

Table 2 Characteristics of 12,159 incident atrial fibrillation patients by medication adherence status

From: Risk factors for medication non-adherence among atrial fibrillation patients

 

Adherent

n = 11,388

(93.7%)

Not Adherent

n = 771

(6.3%)

P†

Socio-demographics

Age, years

  

< 0.001

 Median

72.7

70.1

 

 25th – 75th %

64.4–79.9

59.5–79.1

 

Age group, years, n (%)

  

< 0.001

  < 65

3017 (26.5)

293 (38.0)

 

 65–74

3549 (31.2)

198 (25.7)

 

 75–84

3523 (30.9)

185 (24.0)

 

  ≥ 85

1299 (11.4)

95 (12.3)

 

Male, n (%)

6498 (57.1)

435 (56.4)

0.735

Race/Ethnicity, n (%)

  

< 0.001

 Non-Hispanic White

8505 (74.7)

502 (65.1)

 

 Non-Hispanic Black

572 (5.0)

81 (10.5)

 

 Non-Hispanic Asian/Pacific Islander

775 (6.8)

64 (8.3)

 

 Hispanic

889 (7.8)

75 (9.7)

 

 Other/Unknown

647 (5.7)

49 (6.4)

 

Marital Status, n (%)

  

0.006

 Married/Partner

7470 (65.6)

463 (60.1)

 

 Not Married/Partner

3788 (33.3)

300 (38.9)

 

 Unknown

130 (1.1)

8 (1.0)

 

Educational Attainment, n (%)

  

0.299

 Less than High School

929 (8.2)

72 (9.3)

 

 High School Graduate

2110 (18.5)

145 (18.8)

 

 Some College

4075 (35.8)

290 (37.6)

 

 Bachelor’s Degree or Higher

3999 (35.1)

243 (31.5)

 

 Unknown

275 (2.4)

21 (2.7)

 

Household Income, n (%)

  

0.008

 $25,000 or less

1694 (14.9)

150 (19.5)

 

 $25,001 – 50,000

2477 (21.8)

168 (21.8)

 

 $50,001 – 80,000

1967 (17.3)

122 (15.8)

 

 More than $80,000

2501 (22.0)

169 (21.9)

 

 Unknown

2749 (24.1)

162 (21.0)

 

Questionnaire Language, n (%)

  

0.349

 English

11,077 (97.3)

752 (97.5)

 

 Spanish

280 (2.5)

19 (2.5)

 

 Mandarin

31 (0.3)

0 (0.0)

 

Region, n (%)

  

0.941

 Northern California

5854 (51.4)

395 (51.2)

 

 Southern California

5534 (48.6)

376 (48.8)

 

Health Behaviors

Physical Activity (past month), n (%)

  

< 0.001

 None

854 (7.5)

86 (11.2)

 

 Low/Moderate

7683 (67.5)

532 (69.0)

 

 High

2802 (24.6)

149 (19.3)

 

 Unknown

49 (0.4)

4 (0.5)

 

Cigarette Use (past year), n (%)

  

0.002

 Never

4758 (41.8)

303 (39.3)

 

 Former

5759 (50.6)

383 (49.7)

 

 Current

624 (5.5)

67 (8.7)

 

 Unknown

247 (2.2)

18 (2.3)

 

Alcohol Use (past year), n (%)

  

< 0.001

 Never

2364 (20.8)

105 (13.6)

 

 Former

2245 (19.7)

169 (21.9)

 

 Current

6585 (57.8)

484 (62.8)

 

 Unknown

194 (1.7)

13 (1.7)

 

Self-Reported Health Status

Poor Physical Health (past month), n (%)

  

< 0.001

 0 days

6313 (55.4)

320 (41.5)

 

 1–7 days

2156 (18.9)

196 (25.4)

 

 8–21 days

816 (7.2)

78 (10.1)

 

 22–28 days

80 (0.7)

7 (0.9)

 

  ≥ 29 days

821 (7.2)

74 (9.6)

 

 Unknown

1202 (10.6)

96 (12.5)

 

Poor Mental Health (past month), n (%)

  

< 0.001

 0 days

7835 (68.8)

400 (51.9)

 

 1–7 days

1401 (12.3)

134 (17.4)

 

 8–21 days

593 (5.2)

66 (8.6)

 

 22–28 days

66 (0.6)

6 (0.8)

 

  ≥ 29 days

422 (3.7)

50 (6.5)

 

 Unknown

1071 (9.4)

115 (14.9)

 

Self-Rated Current Health, n (%)

  

< 0.001

 Poor

641 (5.6)

59 (7.7)

 

 Fair

2581 (22.7)

228 (29.6)

 

 Good

4561 (40.1)

271 (35.2)

 

 Very Good

2890 (25.4)

168 (21.8)

 

 Excellent

625 (5.5)

36 (4.7)

 

 Unknown

90 (0.8)

9 (1.2)

 

Sleep Affecting Daily Function (average), n (%)

  

< 0.001

 Never

2747 (24.1)

145 (18.8)

 

 Rarely

5283 (46.4)

294 (38.1)

 

 1–3 days/week

1685 (14.8)

154 (20.0)

 

 4–6 days/week

431 (3.8)

44 (5.7)

 

 Almost every day

1060 (9.3)

126 (16.3)

 

 Unknown

182 (1.6)

8 (1.0)

 

Memory Decline (past 2–3 years), n (%)

  

< 0.001

 No

5582 (49.0)

294 (38.1)

 

 Yes

4601 (40.4)

397 (51.5)

 

 Unknown

1205 (10.6)

80 (10.4)

 

Health Literacy, n (%)

  

< 0.001

 Adequate

8813 (77.4)

536 (69.5)

 

 Inadequate

2575 (22.6)

235 (30.5)

 

Medical History

Low-Dose Aspirin (past year; ≤100 mg/tablet), n (%)

  

0.043

 Did not use in the last 12 mo.

6462 (56.7)

404 (52.4)

 

 Did use in the last 12 mo.

4488 (39.4)

339 (44.0)

 

 Unknown

438 (3.9)

28 (3.6)

 

Aspirin or Aspirin-Product (past year; ≥325 mg/tablet), n (%)

  

0.240

 Did not use in the last 12 mo.

8431 (74.0)

551 (71.5)

 

 Did use in the last 12 mo.

2287 (20.1)

174 (22.6)

 

 Unknown

670 (5.9)

46 (6.0)

 

Body Mass Index (kg/m2), n (%)

  

0.003

  < 25

3211 (28.2)

191 (24.8)

 

 25–30

3915 (34.4)

254 (32.9)

 

  ≥ 30

3492 (30.7)

284 (36.8)

 

 Unknown

770 (6.8)

42 (5.5)

 

Charlson Comorbidity Index (past year), n (%)

  

0.124

 0

3773 (33.1)

255 (33.1)

 

 1

2346 (20.6)

175 (22.7)

 

 2

1652 (14.5)

124 (16.1)

 

  ≥ 3

3617 (31.8)

217 (28.2)

 

CHADS2 Score (past five years), n (%)

  

0.049

 0

1849 (16.2)

155 (20.1)

 

 1

3959 (34.8)

254 (32.9)

 

 2

3782 (33.2)

245 (31.8)

 

  ≥ 3

1798 (15.8)

117 (15.2)

 

Coronary Heart Disease, n (%)

1372 (12.1)

92 (11.9)

0.955

Chronic Heart Failure, n (%)

2457 (21.6)

167 (21.7)

0.964

Dementia, n (%)

288 (2.5)

19 (2.5)

> 0.999

Depression, n (%)

2309 (20.3)

191 (24.8)

0.004

Diabetes Mellitus, n (%)

3096 (27.2)

236 (30.6)

0.041

Hypertension, n (%)

8961 (78.7)

568 (73.7)

0.001

Ischemic Stroke or Transient Ischemic Attack, n (%)

604 (5.3)

39 (5.1)

0.868

  1. †p-values based on chi-square, Fisher’s exact and Wilcoxon signed-rank tests